DIATHESIS HAEMORRHAGIS.

Slides:



Advertisements
Similar presentations
Idiopathic Thrombocytopenic Purpura
Advertisements

Haematology Jennie Wimperis Consultant Haematologist Norfolk and Norwich University Hospital.
» Surface Relations ˃Stomach ˃Renal ˃Colon » Suspended by ˃Phrenosplenic ligament ˃Gastrosplenic ligament ˃Splenocolic ligament ˃Gastrocolic ligament.
Heather D. Mannuel, MD, MBA March 12, 2008
Myeloma Round Table Beth Faiman MSN, APRN-BC, AOCN Nurse Practitioner, Cleveland Clinic Pre-Doctoral Fellow, Case Western Reserve.
Michael F. McNamara, DO Sanford Maternal Fetal Medicine.
بسم الله الرحمن الرحيم.
PLATELETS. PLETELET PHYSIOLOGY Platelets Production: Hematopoietic stem cell  Megakaryoblast  Megakaryocyte  Fragmentation of cytoplasm Platelets.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
IMMUNE THROMBOCYTOPENIA Cathy Payne MSN, ACNP-BC Hematology/Oncology Nurse Practitioner Ironwood Cancer and Research Centers.
Polycythemia Group C: Melanie, Michele, Sarah.
ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Salwa Hindawi. MSc, MRCPath, CTM RCPE Director of Blood Transfusion Services King Abdulaziz University Hospital Jeddah, Saudi Arabia.
LEUKEMIA. What Is It? Leukemia is a type of cancer that starts in the tissue that forms blood.
By Taylor, Lanny, and Alex. What is it?  Leukemia is an abnormal rise in the number of white blood cells. The white blood cells crowd out other blood.
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
Chapter 17 Chronic Leukemias.
November 23, Idiopathic Throbocytopenic Purpura.
DR BINOD KUMAR SINGH Associate Professor, PMCH, Patna CIAP Executive Board Member 2015 NNF State President-2014 IAP State Secretary,Bihar NNF.
Mrs. Mahdia Samaha Alkony. Haemostatic mechanisms  The bleeding vessel constricts  Platelets aggregate at the site, forming an unstable hemostatic plug.
Splenectomy in Hematologic Disorders
NURSING CARE OF THE CHILD WITH A HEMATOLOGIC ALTERATION.
Tuesday Conference Approach to Thrombocytopenia Selim Krim, MD Assistant Professor TTUHSC.
Is Cancer Really that Dangerous? Cause of Death Lifetime odds of dying Car Crash1 in 242 Drowning1 in 1,028 Plane Crash1 in 4,608 Lightning1 in 71,501.
Warm Autoimmune Hemolytic Anemia Lisa Rose-Jones, MD Monday, Aug 24th.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Autoimmunity: Autoimmunity : the immune response which directed against host tissue self epitopes due to loss of tolerance. Self-Tolerance: The non-responsiveness.
IMMUNE THROMBOCYTOPENIC PURPURA (ITP) Dr. Mohamed Haseen Basha Dr. Mohamed Haseen Basha Assistant professor ( Pediatrics) Faculty of Medicine Al Maarefa.
1 CASE REPORT hematology Monika Csóka MD, PhD year old boy no abnormalities in previous anamnesis 2 weeks before viral infection (fever, coughing)
Parvovirus B19 Infections. Pathogenesis Autonomous parvoviruses are highly parasitic because of their molecular simplicity. Autonomous parvoviruses are.
Blood : R2 임규성.  Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by low platelet counts and may be responsible.
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura Journal.
The pathogenesis of immune thrombocytopaenic purpura Nichola Cooper and James Bussel Department of Pediatrics, Weill Medical College of Cornell University,
Dr. A. Carrer Clinica Ematologica ASST- Monza IT P.
Done by : Ahmed Fahad Basilim clinical pharmacist intern Supervised by: Dr. Muna Filfilan.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Use of OCT in Determining Dual Antiplatelet Treatment Duration
IMMUNE PLATELET DESTRUCTION
Anti-thymocyte Globulin (Equine)
Disseminated Intravascular Coagulation
Anti-thymocyte Globulin (Rabbit)
NEONATAL IMMUNE THROMBOCYTOPENIA
Immune thrombocytopenia purpura(ITP)
Blood Biochemistry BCH 577
R1.이용석 / modulator pf.한재준.
IDOPATHIC THROMBOCYTOPENIA PURPURA
Hypersensitivity reactions
Approach to Thrombocytopenia
by Henrik Frederiksen, and Kai Schmidt
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Acquired Immunity.
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to.
Clinical Microbiology and Infection
by Rong Deng, and Joseph P. Balthasar
Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells.
The Fascinating World of Haemostasis and Thrombosis
by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus
Nat. Rev. Rheumatol. doi: /nrrheum
IMMUNE THROMBOCYTOPENIC PURPURA MBBSPPT.COM
Immune thrombocytopenic purpura (ITP)
ACUTE PAIN MANAGEMENT FOR EMS
Albert J. Czaja, Michael P. Manns  Gastroenterology 
Neoplastic disorder.
Chronic ITP Debates & Dilemmas
In the name of God Chronic ITP Debates & Dilemmas
How I vaccinate blood and marrow transplant recipients
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment by Waleed Ghanima, Bertrand Godeau,
Therapy of adult ITP before splenectomy.
Presentation transcript:

DIATHESIS HAEMORRHAGIS

3555555555555555555555555555555555555 HEMOSTASE

TRIAS OF HEMOSTASE VASKULER TROMBOSIT FAKTOR.PEMBEKUAN

FAKTOR ---------- > HEMOSTASE

DIATHESIS HEMORRHAGIS KELAINAN : VASKULER TROMBOSIT FAKTOR PEMBEKUAN

KELAINAN HEMOSTASE

5Kelainan Faktor Pembekuan dengan Kel Vaskuler dan Tromb Kel F 5Kelainan Faktor Pembekuan dengan Kel Vaskuler dan Tromb Kel F.Pemb Kel Vask& Trom 1.Epid : Turunan Turunan/didapat 2. Kelainan : Haematom Purpura/Ekimosis 3. Trauma : + - 4. Lab : W.pemb > W.perd >

ITP 100 cases per 1 milion persons per year. Primary vs Secondary . Acute vs Chronic ( >6 months).

The etiology is still unknown and the pathogenesis is complex and possibly depends on disturbed antigen presentation, T cell activation and signaling, disregulated B cell stimulation and antibodies, unbalanced activation / suppression of complement.

In more than 70% of children, the illness resolves within six months, irrespective of whether they receive therapy. By contrast, ITP in adults is generally chronic.

The bone marrow in patients with ITP contains normal or increased numbers of megakaryocytes.

Pathophysiology ITP is mediated by IgG autoantibodies. Glycoprotein IIb/IIa, Ib/Ix, Ia/IIa, IV and V ... Accelerated clearance through Fcү receptors that are expressed by tissue macrophages (spleen & liver).

TREATMENT The decision to treat ITP is based on the platelet count, the degree of bleeding, and the patient’s lifestyle .

Management The incidence of intracranial hemorrhageis ~ between 0.2-1%. Almost all intracranial hemorrhages occur at platelet counts below 20.000/mm3, and generally below 10.000/mm3. Risk factors : head trauma and exposure to antiplatelet drugs.

Most children with typical acute ITP recover completely within a few weeks without treatment and that there is no proof that therapy prevents intracranial hemorrhage.

American Society of Hematology (ASH) recommends drug therapy for children with platelet counts of less than 10.000/mm3 with little or no purpura.

Treatment Watch & Wait strategy. Immunosupresive - Corticosteroids (high, standard or low dose). - Azathioprine IVIG (high or low dose, 2 day or 1 day). IV anti-D immunoglobulin in Rh(D) positive patients (high or low dose). Splenectomi